InvestorsHub Logo
icon url

steelyeye

08/20/20 5:25 PM

#319528 RE: farrell90 #319522

And add to those PRs you mention from 2/18 onward, the previous ones that show Brilacidin's excellent safety record and indications of efficacy in three separate phase 2 trials addressing three different indications:
OM, ABSSSI, and UP.

The above DD is for potential new investors to take a good look and see the explosive potential here. Brilacidin is a compound with 3 MOAs, an excellent safety record and recent in vitro COV-19 lab results that have been outstanding...



If you read and understand the IPIX PRs from 2/18 forward you will see a progressive volume of scientific evidence which shows Brilacidin has impressive in vitro action against Covid 19.

Imo this should lead to human clinical trials, funding and even partnerships to quickly expedite the study of Brilacidin as an antiviral against Covid 19.